ニューハンプシャー州における肺がんの臨床試験
ニューハンプシャー州内の拠点で、肺がんに関する12件の研究が参加者を募集しています。
ニューハンプシャー州内の都市
公式研究テキスト（英語）
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
- The Dana-Farber Cancer Institute at Londonderry, Londonderry
被験者募集中第3相
70歳以上 · 全性別 · 2026/10/05更新 · NCT06096844Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- New Hampshire Oncology Hematology PA-Concord, Concord
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
- Solinsky Center for Cancer Care, Manchester
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/05更新 · NCT04267848Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- New Hampshire Oncology Hematology PA-Concord, Concord
- Solinsky Center for Cancer Care, Manchester
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
- Dartmouth-Hitchcock Medical Center, Lebanon
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT06881784A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
- Local Institution - 0467, Lebanon
- Local Institution - 0600, Manchester
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07063745A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Dartmouth-Hitchcock Medical Center, Lebanon
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT05624996Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- New Hampshire Oncology Hematology PA-Concord, Concord
- Solinsky Center for Cancer Care, Manchester
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/03更新 · NCT05642572Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- New Hampshire Oncology Hematology PA-Concord, Concord
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
- Solinsky Center for Cancer Care, Manchester
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/05/05更新 · NCT06616584Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- New Hampshire Oncology Hematology PA-Concord, Concord
- Solinsky Center for Cancer Care, Manchester
被験者募集中第2相
18 Minutes · 全性別 · 2026/05/05更新 · NCT06031688A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
- Dartmouth Hitchcock Medical Center, Lebanon
被験者募集中第1相
18歳以上 · 全性別 · 2026/03/20更新 · NCT05948865Healthy Homes Study
- Dartmouth Cancer Center, Lebanon
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/01/30更新 · NCT05833334ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。